Antiatherogenic effects of thiazolidinediones?
C K
CK
Glass
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D002465:Cell Movement / Q000187:drug effects; D002839:Chromans / Q000494:pharmacology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004041:Dietary Fats / Q000008:administration & dosage; D006801:Humans; D009000:Monocytes / Q000166:cytology / Q000187:drug effects; D011973:Receptors, LDL / Q000172:deficiency* / Q000235:genetics; D013844:Thiazoles / Q000494:pharmacology*; D045162:Thiazolidinediones; D000077288:Troglitazone; D014665:Vasodilator Agents / Q000494:pharmacology*
D002839:Chromans; D004041:Dietary Fats; D011973:Receptors, LDL; D013844:Thiazoles; D045162:Thiazolidinediones; D014665:Vasodilator Agents; D000077288:Troglitazone